MARKET

NTRA

NTRA

Natera Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

35.93
-0.74
-2.02%
After Hours: 36.60 +0.67 +1.86% 17:40 05/18 EDT
OPEN
35.40
PREV CLOSE
36.67
HIGH
38.58
LOW
35.40
VOLUME
1.38M
TURNOVER
7.90M
52 WEEK HIGH
129.09
52 WEEK LOW
26.10
MARKET CAP
3.46B
P/E (TTM)
-6.1066
1D
5D
1M
3M
1Y
5Y
8 Analysts Have This to Say About Natera
Within the last quarter, Natera (NASDAQ:NTRA) has observed the following analyst ratings:
Benzinga · 2d ago
BRIEF-Matthew Rabinowitz, Natera Co-Founder And Executive Chairman Of The Board, Makes Additional Investment In Co
reuters.com · 2d ago
Piper Sandler Adjusts Natera's Price Target to $60 From $75, Reiterates Overweight Rating
MT Newswires · 2d ago
Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Simply Wall St. · 05/10 18:03
--JPMorgan Adjusts Price Target for Natera to $80 From $150, Maintains Overweight Rating
MT Newswires · 05/09 12:12
--Morgan Stanley Lowers Natera's Price Target to $70 From $110, Maintains Overweight Rating
MT Newswires · 05/09 12:05
Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance
Benzinga · 05/06 18:21
Natera rallies on Q1 estimates beat, increased 2022 revenue guidance
Natera (NTRA) rallies 4% premarket as the Co. reported Q1 revenues of $194.1M beating estimates by $17.5M, where Product revenues were $190M, an increase of 57.8% Y/Y. The Co. processed ~489,300 tests
Seekingalpha · 05/06 13:11
More
No Data
Learn about the latest financial forecast of NTRA. Analyze the recent business situations of Natera Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

41.67%Strong Buy
50.00%Buy
8.33%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NTRA stock price target is 85.20 with a high estimate of 150.00 and a low estimate of 54.00.
High150.00
Average85.20
Low54.00
Current 35.93
EPS
Actual
Estimate
-1.30-0.98-0.65-0.33
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 406
Institutional Holdings: 109.43M
% Owned: 113.62%
Shares Outstanding: 96.31M
TypeInstitutionsShares
Increased
127
5.75M
New
47
4.88M
Decreased
119
9.49M
Sold Out
66
1.04M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.72%
Healthcare Equipment & Supplies
-2.33%
Key Executives
Chairman/Co-Founder/Executive Director
Matthew Rabinowitz
President/Chief Executive Officer/Director
Steven Chapman
Co-Founder/Director
Jonathan Sheena
Chief Financial Officer/IR Contact Officer
Michael Brophy
Chief Operating Officer
Robert Schueren
Secretary
Daniel Rabinowitz
Lead Director/Independent Director
Roelof Botha
Independent Director
Roy Baynes
Independent Director
Monica Bertagnolli
Independent Director
Rowan Chapman
Independent Director
Todd Cozzens
Independent Director
James Healy
Independent Director
Gail Marcus
Independent Director
Herman Rosenman
No Data
No Data
About NTRA
Natera, Inc. is a diagnostics company. The Company is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. The Company’s cell-free DNA (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology.

Webull offers kinds of Natera Inc stock information, including NASDAQ:NTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTRA stock methods without spending real money on the virtual paper trading platform.